Skip to main content
Qiagen N.V. logo

Qiagen N.V. — Investor Relations & Filings

Ticker · QIA ISIN · NL0015001WM6 LEI · 54930036WK3GMCN17Z57 F Manufacturing
Open in API
Filings indexed 627 across all filing types
Latest filing 2013-07-03 Regulatory Filings
Country NL Netherlands
Listing F QIA

About Qiagen N.V.

https://www.qiagen.com/

Qiagen N.V. is a global provider of "Sample to Insight" solutions, offering technologies that transform biological materials into valuable molecular insights. The company develops and markets sample and assay technologies, automated instrumentation, and bioinformatics software for molecular diagnostics, applied testing, academic research, and pharmaceutical development. Its comprehensive portfolio supports the entire workflow from sample collection and preparation of DNA, RNA, and proteins to analysis and interpretation. Key product areas include sample preparation kits, PCR, digital PCR (dPCR), and next-generation sequencing (NGS) solutions, as well as syndromic testing panels for infectious diseases.

Recent filings

Filing Released Lang Actions
Regulatory Filings 2013
Regulatory Filings Classification · 95% confidence The document is a letter from the company's legal counsel to the SEC requesting an extension of time to respond to an SEC comment letter regarding the company's Form 20-F for the year ended December 31, 2012. It does not contain financial data, audit results, or the report itself, but is a regulatory correspondence related to the filing process. The document length is short (2486 characters) and it is a formal request for extension, not the report or a certification. Therefore, it fits best under Regulatory Filings (RNS) as a general regulatory announcement and correspondence with the SEC.
2013-07-03 English
Regulatory Filings 2013
Regulatory Filings
2013-06-19 English
Regulatory Filings 2013
Regulatory Filings Classification · 95% confidence The document is a detailed response letter from the company's legal counsel to the SEC staff regarding comments on the company's Form 20-F for the fiscal year ended December 31, 2012. It discusses accounting policies, revenue recognition, and proposed disclosure revisions for future filings. The document is not the Form 20-F itself but a correspondence addressing SEC comments on that filing. It is filed under the form type CORRESP, indicating correspondence rather than a primary financial report. The content is regulatory in nature, responding to SEC inquiries and clarifying accounting treatments, which fits the category of Regulatory Filings (RNS). The document length is substantial but it does not contain the full annual report or financial statements, only commentary and responses to SEC staff comments.
2013-05-24 English
Regulatory Filings 2013
Regulatory Filings
2013-05-14 English
Interim / Quarterly Report 2013
Interim / Quarterly Report Classification · 100% confidence The document is a Form 6-K filed with the SEC by QIAGEN N.V., a foreign private issuer. It contains a quarterly report for the period ended March 31, 2013, including condensed consolidated financial statements (balance sheets, income statements, etc.). Since it provides comprehensive financial data for a period shorter than a full fiscal year, it is classified as an Interim/Quarterly Report. Q1 2013
2013-04-30 English
6-K
Interim / Quarterly Report Classification · 100% confidence The document is a Form 6-K filed by QIAGEN N.V. for the quarterly period ended March 31, 2013. It contains detailed unaudited condensed consolidated financial statements including balance sheets, income statements, statements of comprehensive income, changes in equity, and cash flows, along with notes and management discussion sections such as Operating and Financial Review and Prospects, and Quantitative and Qualitative Disclosures About Market Risk. The presence of actual financial data and comprehensive financial analysis for a quarterly period indicates this is an Interim / Quarterly Report. The document is not a brief announcement or a certification, but a full quarterly financial report under U.S. GAAP. Therefore, the correct classification is Interim / Quarterly Report (IR).
2013-04-30 English

Browse filings by year

29 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.